Search company, investor...

Osteotech

osteotech.com

Founded Year

1986

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Osteotech

Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company's current and development-stage technologies address needs within numerous musculoskeletal disciplines.

Headquarters Location

51 James Way

Eatontown, New Jersey, 07724,

United States

732-542-2800

Missing: Osteotech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Osteotech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Osteotech Patents

Osteotech has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/5/2007

5/10/2011

Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials

Grant

Application Date

12/5/2007

Grant Date

5/10/2011

Title

Related Topics

Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials

Status

Grant

Latest Osteotech News

StreetInsider.com - Osteotech Acquired by Medtronic for $123 Million

Jul 17, 2013

Send to a Friend Font Size: Increase Decrease Osteotech/Medtronic On August 17, 2010, Osteotech (Nasdaq: OSTE) announced an agreement to be acquired by Medtronic Inc., (NYSE: MDT) for $6.50 per share in cash, or approximately $123 million. Osteotech is a leader in the growing field of biologic products for regenerative healing, and has pioneered several innovative technology platforms including Grafton demineralized bone matrix, a family of products which has a large and growing body of evidence supporting its best-in-class bone generating capabilities.

Osteotech Frequently Asked Questions (FAQ)

  • When was Osteotech founded?

    Osteotech was founded in 1986.

  • Where is Osteotech's headquarters?

    Osteotech's headquarters is located at 51 James Way, Eatontown.

  • What is Osteotech's latest funding round?

    Osteotech's latest funding round is Acq - P2P.

  • Who are the investors of Osteotech?

    Investors of Osteotech include Medtronic, Sycamore Ventures, Franklin Street Equity Partners, First Health Group, DLB Capital and 3 more.

  • Who are Osteotech's competitors?

    Competitors of Osteotech include Apollo Endosurgery, Suneva Medical, SynCardia Systems, Axion BioSystems, Healionics, Noraker, MedShape, HemoShear Therapeutics, Wright Medical Group, OrthAlign and 56 more.

Compare Osteotech to Competitors

S
Serica Technologies

Serica is a medical device company focused on the development of silk-based biomaterial platforms that may be used in tissue repair. The company's approach leverages natural silk in combination with advances in biomedical engineering to address needs in the repair of damaged connective tissue, caused by disease, trauma, or aging. Serica's products are being studied for use in orthopaedics and sports medicine, aesthetic and reconstructive plastic surgery, and multiple additional structural tissue repair applications.

S
SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.

G
Graphic Surgery

Graphic Surgery is a physician founded medical service company founded in 2000, which aims to ensure that consumers have the right surgery at the right time with the right outcome. They work with surgeons, employers and insurers to educate consumers about the most common surgeries and to promote transparency. This information aims to provide consumers the knowledge and confidence to select the right providers, discuss all treatment options and have better outcomes when they do have surgery. There are currently 3 main products. Surgery Insight, Surgery Analytics and Surgery By Design.

E
Es Vascular

ES Vascular Ltd. developed first ever surgical stapling devices for endovascular surgery. These devices aim to transform vascular surgery by shortening procedural times, and by simplifying and potentially increasing the safety of the most common vascular interventions. The company is currently developing three product lines for open AAA, endovascular AAA and Femoro-Pop bypass procedures. Its first products are anticipated to enter the market in 2008.nCompany Snapshotn Started in 2000 in Israel by Prof. Shifrin together with group of engineers and leading vascular surgeons from the US and Europe;n Developed a ever vascular stapling technology for stapling synthetic grafts to the aortan Developed endovascular devices for EVAR and SFA procedures

J
J-pac

J-PAC is a supplier of medical contract manufacturing, assembly, and packaging services. Participating as a member of the Medipharm Manufacturing Group, J-PAC offers a "Continuum of Service" that starts with the package design, product prototyping and clinical trials leading to full scale medical device production.n

C
Cascade Life Solutions

Cascade Life Solutions is an FDA registered, ISO certified company engaged in medical device contract manufacturing and assembly. Cascade Life's focus is to provide "single source" for medical device contract manufacturing (class I, II and III) services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.